Anastassios C Koumbourlis1, Donna J Lee, Ada Lee. 1. Division of Pediatric Pulmonology, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center, New York, NY, USA. Akoumbou@LIJ.edu
Abstract
BACKGROUND: We studied the changes in the patterns of lung function and somatic growth over time in children and adolescents (10.6 +/- 3.5 years at first test) with hemoglobin SS (Hb-SS) sickle cell disease (SCD). METHODS: Lung function and somatic growth were measured twice with an interval of 42.3 +/- 23.3 months in 45 children (25 females and 20 males) with Hb-SS SCD. RESULTS: The lung volumes slightly decreased but remained borderline normal in both tests. All spirometric indices were within the normal range but significantly decreased (P<0.001) at the time of the second test indicating development of lower airway obstruction (forced expiratory volume in the first second (FEV(1)): 87 +/- 21 vs. 80 +/- 15; FEV(1)/forced vital capacity (FVC): 89 +/- 7 vs. 85 +/- 6; FEF(25-75): 89 +/- 32 vs. 76 +/- 24). "Normal" pattern of lung function was initially found in 56% of the patients, but in only 29% in the second test. In contrast, those with "obstructive" pattern increased from 22 to 44%, and those with "restrictive" pattern from 22 to 27%. There was no association between history of asthma and pattern of lung function. "Normal" Body Mass Index (BMI) was found in 64% of the patients, whereas 13% had "High" BMI and 22% "Low" BMI. The two latter patterns were associated with abnormal lung function but only patients with normal BMI showed actual decline overtime. CONCLUSION: SCD is characterized by a predominantly obstructive pattern of lung function that increases in prevalence over time. There was no apparent causal relationship between the pattern of somatic growth and the pattern of lung function. (c) 2007 Wiley-Liss, Inc.
BACKGROUND: We studied the changes in the patterns of lung function and somatic growth over time in children and adolescents (10.6 +/- 3.5 years at first test) with hemoglobin SS (Hb-SS) sickle cell disease (SCD). METHODS: Lung function and somatic growth were measured twice with an interval of 42.3 +/- 23.3 months in 45 children (25 females and 20 males) with Hb-SS SCD. RESULTS: The lung volumes slightly decreased but remained borderline normal in both tests. All spirometric indices were within the normal range but significantly decreased (P<0.001) at the time of the second test indicating development of lower airway obstruction (forced expiratory volume in the first second (FEV(1)): 87 +/- 21 vs. 80 +/- 15; FEV(1)/forced vital capacity (FVC): 89 +/- 7 vs. 85 +/- 6; FEF(25-75): 89 +/- 32 vs. 76 +/- 24). "Normal" pattern of lung function was initially found in 56% of the patients, but in only 29% in the second test. In contrast, those with "obstructive" pattern increased from 22 to 44%, and those with "restrictive" pattern from 22 to 27%. There was no association between history of asthma and pattern of lung function. "Normal" Body Mass Index (BMI) was found in 64% of the patients, whereas 13% had "High" BMI and 22% "Low" BMI. The two latter patterns were associated with abnormal lung function but only patients with normal BMI showed actual decline overtime. CONCLUSION:SCD is characterized by a predominantly obstructive pattern of lung function that increases in prevalence over time. There was no apparent causal relationship between the pattern of somatic growth and the pattern of lung function. (c) 2007 Wiley-Liss, Inc.
Authors: Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse Journal: Pediatr Allergy Immunol Pulmonol Date: 2017-12-01 Impact factor: 1.349
Authors: Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun Journal: Am J Hematol Date: 2018-01-25 Impact factor: 10.047
Authors: Jennifer M Knight-Madden; Antoinette Barton-Gooden; Steve R Weaver; Marvin Reid; Anne Greenough Journal: Lung Date: 2012-11-13 Impact factor: 2.584
Authors: Marthe-Sandrine Eiymo Mwa Mpollo; Eric B Brandt; Shiva Kumar Shanmukhappa; Paritha I Arumugam; Swati Tiwari; Anastacia Loberg; Devin Pillis; Tilat Rizvi; Mark Lindsey; Bart Jonck; Peter Carmeliet; Vijay K Kalra; Timothy D Le Cras; Nancy Ratner; Marsha Wills-Karp; Gurjit K Khurana Hershey; Punam Malik Journal: J Clin Invest Date: 2015-12-21 Impact factor: 14.808
Authors: Jeffrey A Glassberg; Annie Chow; Juan Wisnivesky; Ronald Hoffman; Michael R Debaun; Lynne D Richardson Journal: Br J Haematol Date: 2012-09-12 Impact factor: 6.998
Authors: Bruce A Ong; Jason Caboot; Abbas Jawad; Joseph McDonough; Tannoa Jackson; Raanan Arens; Carole L Marcus; Kim Smith-Whitley; Thornton B A Mason; Kwaku Ohene-Frempong; Julian L Allen Journal: Br J Haematol Date: 2013-07-20 Impact factor: 6.998